Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2003 Jun;7(3):R35-40.
doi: 10.1186/cc2185. Epub 2003 Apr 24.

Erythropoietin mimics the acute phase response in critical illness

Affiliations
Clinical Trial

Erythropoietin mimics the acute phase response in critical illness

John Michael Elliot et al. Crit Care. 2003 Jun.

Abstract

Background: In a prospective observational study, we examined the temporal relationships between serum erythropoietin (EPO) levels, haemoglobin concentration and the inflammatory response in critically ill patients with and without acute renal failure (ARF).

Patients and method: Twenty-five critically ill patients, from general and cardiac intensive care units (ICUs) in a university hospital, were studied. Eight had ARF and 17 had normal or mildly impaired renal function. The comparator group included 82 nonhospitalized patients with normal renal function and varying haemoglobin concentrations. In the patients, levels of haemoglobin, serum EPO, C-reactive protein, IL-1beta, IL-6, serum iron, ferritin, vitamin B12 and folate were measured, and Coombs test was performed from ICU admission until discharge or death. Concurrent EPO and haemoglobin levels were measured in the comparator group.

Results: EPO levels were initially high in patients with ARF, falling to normal or low levels by day 3. Thereafter, almost all ICU patients demonstrated normal or low EPO levels despite progressive anaemia. IL-6 exhibited a similar initial pattern, but levels remained elevated during the chronic phase of critical illness. IL-1beta was undetectable. Critically ill patients could not be distinguished from nonhospitalized anaemic patients on the basis of EPO levels.

Conclusion: EPO levels are markedly elevated in the initial phase of critical illness with ARF. In the chronic phase of critical illness, EPO levels are the same for patients with and those without ARF, and cannot be distinguished from noncritically ill patients with varying haemoglobin concentrations. Exogenous EPO therapy is unlikely to be effective in the first few days of critical illness.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Box and whisker plot of erythropoietin (EPO) concentrations against time for all patients. Hollow circles indicate outliers (cases with values of the variable between 1.5 and 3 times the length of the corresponding box for that day and group); filled circles indicate extreme values (cases with values greater than 3 times the corresponding box for that day and group). ARF, acute renal failure.
Figure 2
Figure 2
Box and whisker plot of haemoglobin concentrations against time for all patients. Hollow circles indicate outliers (cases with values of the variable between 1.5 and 3 times the length of the corresponding box for that day and group); filled circles indicate extreme values (cases with values greater than 3 times the corresponding box for that day and group). ARF, acute renal failure.
Figure 3
Figure 3
Box and whisker plot of IL-6 concentrations against time for all patients. Hollow circles indicate outliers (cases with values of the variable between 1.5 and 3 times the length of the corresponding box for that day and group); filled circles indicate extreme values (cases with values greater than 3 times the corresponding box for that day and group). ARF, acute renal failure.
Figure 4
Figure 4
Analysis of median levels of erythropoietin (EPO) and haemoglobin (Hb) for cases (using all data from each patient), compared with comparator group subjects (single data values). (Comparator group subjects are referred to as 'controls'.) ARF, acute renal failure.

Similar articles

Cited by

References

    1. Rogiers P, Zhang H, Leeman M, Nagler J, Neels H, Melot C, Vincent J-L. Erythropoietic response is blunted in critically ill patients. Intensive Care Med. 1997;23:159–162. doi: 10.1007/s001340050310. - DOI - PubMed
    1. Von Ahsen N, Muller C, Serke S, Frei U, Eckardt K-U. Important role of nondiagnostic blood loss and blunted erythropoietic response in the anaemia of medical intensive care patients. Crit Care Med. 1999;27:2630–2639. - PubMed
    1. Hobisch-Hagen P, Wiedermann F, Mayr A, Fries D, Jelkmann W, Fuchs D, Hasibeder W, Mutz N, Klingler A, Schobersberger W. Blunted erythropoietic response to anemia in multiply traumatized patients. Crit Care Med. 2001;29:743–737. - PubMed
    1. Kraus P, Lipman J. Erythropoietin in a patient following multiple trauma. Anaesthesia. 1992;47:962–964. - PubMed
    1. Koestner JA, Nelson LD, Morris JA, Safcsak K. Use of recombinant human erythropoietin (r-HuEPO) in a Jehovah's witness refusing transfusion of blood products. J Trauma. 1990;30:1406–1408. - PubMed

Publication types

MeSH terms